iX Biopharma42C 
$0.023.85%24h
3.85%24h
Global rank31059
Market cap$15.96M
Change 7d3.85%
YTD Performance-40.00%
SP500 benchmarkUnderperform
P/E0
P/S3.50
Revenue$4.56M
Earnings-$7.42M
Dividend yield-
Main Sector
Healthcare
Category
EPS for iX Biopharma (42C)
iX Biopharma has an EPS of $-0.0062. In 2021, the company made an earnings per share (EPS) of $-0.0119. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for 42C
-
Value:-
EPS history for iX Biopharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | -$0.0062 | -47.90% |
| 2021 | -$0.0119 | -26.54% |
| 2020 | -$0.0162 | - |
View the highest EPS stocks
